Ingredient concern

Coal Tar Dyes and P-Phenylenediamine

HIGH SEVERITY EU RESTRICTS PPD IN HAIR DYE TO 2%; BANNED IN EYEBROW/EYELASH USE; FDA PERMITS IN HAIR DYE WITH WARNING LABEL

PPD is the primary oxidative dye in permanent hair color. IARC classifies occupational exposure to hairdressers as Group 2A (probably carcinogenic). EU bans in eyebrow/eyelash dyes and caps at 2% in hair dye. FDA permits with warning label for skin sensitization.

What you need to know

P-phenylenediamine (PPD) is a synthetic chemical compound that serves as the primary oxidative dye in permanent hair coloring products. When mixed with hydrogen peroxide during the coloring process, PPD undergoes oxidation to create long-lasting color molecules that bind to hair. It is one of the most widely used ingredients in permanent hair dyes globally and has been in cosmetic use for decades. PPD is distinct from other hair dye components and is valued by manufacturers for its ability to produce a wide range of dark and natural-looking shades, making it a staple in both professional salon products and at-home hair color kits. The health concerns surrounding PPD center on two primary issues: acute skin sensitization and potential long-term carcinogenic risk. Acute allergic contact dermatitis from PPD is well-documented, with some individuals experiencing severe reactions including swelling, blistering, and systemic symptoms. More significantly, the International Agency for Research on Cancer (IARC) classified occupational exposure to hair dyes and hair dye work as Group 2A—probably carcinogenic to humans—based on epidemiological evidence in hairdressers and barbers. While IARC's assessment focused on occupational exposure rather than consumer use, the classification reflects concern about cumulative exposure to PPD and related chemicals. The distinction between occupational and consumer risk remains important: hairdressers may apply dyes dozens of times weekly with potential for inhalation and dermal absorption, whereas consumers typically color hair every four to twelve weeks. Regulatory approaches to PPD differ significantly between major markets. The European Union has taken the most restrictive stance, banning PPD entirely in eyebrow and eyelash dyes and capping its concentration at 2 percent in hair dyes, with mandatory warning labels about skin sensitization risk. The FDA permits PPD in hair dyes at higher concentrations but requires warning labels on products alerting consumers to the risk of allergic contact dermatitis and recommending a patch test before use. The FDA has not classified PPD as a carcinogen for consumer use and continues to permit its use in hair coloring products. Some U.S. states, including California, have not implemented additional restrictions beyond federal requirements, though consumer advocacy groups including the Environmental Working Group (EWG) have documented PPD in widely available products and flagged the IARC classification in their ingredient safety database. Consumers concerned about PPD exposure have several options. The most direct approach is to read product labels and avoid permanent hair dyes listing PPD or p-phenylenediamine in the ingredient list; many brands now market PPD-free permanent and semi-permanent alternatives using different oxidative dyes or plant-based colorants, though these may offer different color ranges or longevity. Consumers can also perform patch tests 48 hours before application as recommended by the FDA to identify sensitivity. Those seeking to minimize chemical exposure may consider semi-permanent dyes, which typically use smaller molecules that do not require oxidation and often exclude PPD, or temporary color options including rinses and glazes. Professional colorists can discuss alternative dye chemistries and may be familiar with PPD-free product lines. For individuals with a known PPD allergy, hypoallergenic or alternative-chemistry dyes are increasingly available, though consumers should verify ingredient lists rather than relying on marketing claims alone.

Primary sources (4)
  1. monographs.iarc.who.int
  2. ec.europa.eu
  3. fda.gov
  4. ewg.org

No implicated brands on record

We only list brands once we have a primary-source link tying them to this issue. Nothing on file yet.